Literature DB >> 27259694

Analysıs of gene copy number changes ın head and neck cancer.

E Baltaci1, E Karaman2, N Dalay3, N Buyru1.   

Abstract

OBJECTIVE: Chromosomal alterations and copy number changes are frequent events in tumors, leading to amplification of focal regions containing several oncogenes. Gains and losses of several regions have been reported in head and neck cancer (HNC) but the copy number changes of the individual genes located in these regions have not been analyzed so far. In this study we aimed to analyze the copy number variations in patients with HNC.
DESIGN: Prospective study
SETTING: University hospital PARTICIPANTS: 50 patients with squamous cell carcinoma of the head and neck
METHODS: Copy number changes and amplifications of 22 genes in tumors and matched tissue were analyzed by MLPA which allows simultaneous analysis of gene copy numbers in multiple genetic regions.
RESULTS: Amplifications were observed in 52% and losses were detected in 20% of the samples. Chromosome 8 was found to harbor the most frequent copy number alterations. The most frequently amplified genes were CCND1 and the MED1 genes followed by the MTDH and MYC genes on the long arm and ZNF703 on the short arm of chromosome 8. Amplification of the ZNF703, PRDM14 and MYC genes were highly correlated suggesting that the genes displaying high copy number changes on chromosome 8 collaborate during carcinogenesis.
CONCLUSIONS: The alterations found in our study supports the contribution of gene amplifications and indicate cooperation between certain oncogenes in the pathogenesis of HNSCC. Correlations between amplification of less familiar genes and known oncogenes warrant further investigation. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2016        PMID: 27259694     DOI: 10.1111/coa.12686

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  8 in total

Review 1.  Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.

Authors:  Lauren J Tracey; Monica J Justice
Journal:  Trends Genet       Date:  2019-05-23       Impact factor: 11.639

2.  MiR-98 inhibits malignant progression via targeting MTDH in squamous cell carcinoma of the head and neck.

Authors:  Haolei Tan; Gangcai Zhu; Li She; Ming Wei; Yunyun Wang; Leiming Pi; Changhan Chen; Diekuo Zhang; Pingqing Tan; Jie Chen; Donghai Huang; Yongquan Tian; Yong Liu; Xin Zhang
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

3.  Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer.

Authors:  Ceren Orhan; Pelin Bulut; Nejat Dalay; Ezel Ersen; Nur Buyru
Journal:  Mol Biol Rep       Date:  2019-07-18       Impact factor: 2.316

4.  ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes.

Authors:  Elise Klæstad; Joanna Ewa Sawicka; Monica Jernberg Engstrøm; Borgny Ytterhus; Marit Valla; Anna Mary Bofin
Journal:  Breast Cancer Res Treat       Date:  2021-01-02       Impact factor: 4.872

5.  CT120: A New Potential Target for c-Myc in Head and Neck Cancers.

Authors:  Elif Baltaci; Betül Seyhan; Onur Baykara; Nur Buyru
Journal:  J Cancer       Date:  2017-03-07       Impact factor: 4.207

6.  Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14.

Authors:  Kohzoh Imai; Hiroaki Taniguchi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2022       Impact factor: 3.945

7.  Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma.

Authors:  Sufeng Zhao; Li An; Xudong Yang; Zheng Wei; He Zhang; Yufeng Wang
Journal:  Front Oncol       Date:  2022-08-31       Impact factor: 5.738

Review 8.  Multifaceted Role of PRDM Proteins in Human Cancer.

Authors:  Amelia Casamassimi; Monica Rienzo; Erika Di Zazzo; Anna Sorrentino; Donatella Fiore; Maria Chiara Proto; Bruno Moncharmont; Patrizia Gazzerro; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.